REQUEST A DEMO
Total
USD $0.00
Search more companies

Saneca Pharmaceuticals a. s. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Saneca Pharmaceuticals a. s. Profile Updated: March 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Saneca Pharmaceuticals a. s. is an enterprise based in Slovakia. Its main office is in Hlohovec. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on September 19, 2012. It currently has a total number of 500 - 999 (2023) employees. From the latest financial highlights, Saneca Pharmaceuticals a. s. reported a net sales revenue increase of 19.26% in 2022. Over the same period, its total assets grew by 7.21%. In 2022, Saneca Pharmaceuticals a. s.’s net profit margin decreased by 0.01%.

Headquarters
Nitrianska 100
Hlohovec; Trnavsky; Postal Code: 92027

Contact Details: Purchase the Saneca Pharmaceuticals a. s. report to view the information.

Website: http://www.saneca.com/sk/

Basic Information
Total Employees:
Purchase the Saneca Pharmaceuticals a. s. report to view the information.
Outstanding Shares:
Purchase the Saneca Pharmaceuticals a. s. report to view the information.
Registered Capital:
Purchase the Saneca Pharmaceuticals a. s. report to view the information.
Incorporation Date:
September 19, 2012
Key Executives
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Saneca Pharmaceuticals a. s. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
19.26%
Total operating revenue
18.54%
Operating profit (EBIT)
136.47%
EBITDA
90.2%
Net Profit (Loss) for the Period
18.88%
Total assets
7.21%
Total equity
9.67%
Operating Profit Margin (ROS)
1.52%
Net Profit Margin
-0.01%
Return on Equity (ROE)
0.44%
Debt to Equity Ratio
-1.9%
Quick Ratio
0.02%
Cash Ratio
0%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?